GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; pharmacologic profile of the benzodiazepine antagonist, flumazenil (Q41039991)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 1995

Language	Label	Description	Also known as
English	GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; pharmacologic profile of the benzodiazepine antagonist, flumazenil	scientific article published on July 1995

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; pharmacologic profile of the benzodiazepine antagonist, flumazenil (English)

1 reference

Europe PubMed Central

25 September 2017

author name string

Marczynski TJ

1

1 reference

Europe PubMed Central

25 September 2017

publication date

1 July 1995

1 reference

Europe PubMed Central

25 September 2017

Reviews in the Neurosciences

1 reference

Europe PubMed Central

25 September 2017

6

1 reference

Europe PubMed Central

25 September 2017

3

1 reference

Europe PubMed Central

25 September 2017

221-258

1 reference

Europe PubMed Central

25 September 2017

Specific changes in local cerebral glucose utilization in the rat brain induced by acute and chronic diazepam.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Interchangeability of stress and amphetamine in sensitization

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Catecholamines and cognitive decline in aged nonhuman primates.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Effect of benzodiazepines and pentobarbital on the GABA-induced depolarization in cultured astrocytes.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Ultrastructural localization of protein kinase C beta-subspecies in the axon terminal of rat neuromuscular junction

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Alzheimer's disease. A metabolic systems degeneration?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Functional interaction between benzodiazepine and GABA recognition sites in aged rats

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Brain Acetylcholine and Habituation

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Changes in cortical acetylcholine output induced by modulation of the nucleus basalis.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Neuron numbers and dendritic extent in normal aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The somatostatin analogue SMS 201-995 promotes paradoxical sleep in aged rats.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Neuron atrophy during aging: programmed or sporadic?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Age-dependent enhancement of diazepam sensitivity is accelerated in New Zealand Black mice

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The role of pre-synaptic GABA and benzodiazepine receptors in the control of noradrenaline release in rat hippocampus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Age-related impairments in spatial memory are independent of those in sensorimotor skills

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Benzodiazepines: Potentiation of a GABA inhibitory response in the dorsal raphe nucleus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Brain G-protein proteolysis by calpain: enhancement by lithium.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

GABAA receptor modulation of memory: the role of endogenous benzodiazepines

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Loss of NGF receptor immunoreactivity in basal forebrain neurons of aged rats: correlation with spatial memory impairment

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Nerve growth factor treatment after brain injury prevents neuronal death

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Flumazenil improves active avoidance performance in aging NZB/BlNJ and C57BL/6NNia mice.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Brain Aging Correlates: Retardation by Hormonal-Pharmacological Treatments

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Non-motor microtubule-associated proteins.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Contributory mechanisms in the causation of neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Reserpine and the role of axonal transport in the independent regulation of pre- and postsynaptic β-adrenoreceptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Brain cholinergic dysfunction and memory in aged rats

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Age and sex-dependent decreases in ChAT in basal forebrain nuclei

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The Biochemistry of Memory: A New and Specific Hypothesis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Classical conditioning of the rabbit eyelid response increases glutamate receptor binding in hippocampal synaptic membranes

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Adenosine presynaptic inhibition and transmitter "spillover": a new hypothesis of etiopathogenesis of narcolepsy

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Sleep and purposive behavior: inverse deviations from randomness of neuronal firing patterns in the feline thalamus. A new form of homeostasis?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Chronic administration of flumazenil increases life span and protects rats from age-related loss of cognitive functions: a benzodiazepine/GABAergic hypothesis of brain aging

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Animal models of chronic anxiety and "fearlessness".

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Effect of basic fibroblast growth factor on neurons cultured from various regions of postnatal rat brain.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Aging: effect on the interaction of ethanol and pentobarbital with the benzodiazepine-GABA receptor-ionophore complex

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Acidic fibroblast growth factor delays in vitro ischemia-induced intracellular calcium elevation in gerbil hippocampal slices: a sign of neuroprotection

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Stress induces neuronal death in the hippocampus of castrated rats.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Intraventricular nerve growth factor administration prevents lesion-induced loss of septal cholinergic neurons in aging rats

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Chronic Ro 15–1788 treatment increases REM sleep in rats

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Programmed cell death and the control of cell survival: lessons from the nervous system

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Potential behavioral modification of glucocorticoid damage to the hippocampus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Acidic fibroblast growth factor prevents death of hippocampal CA1 pyramidal cells following ischemia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Feasibility of reversing benzodiazepine tolerance with flumazenil

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Nerve growth factor (NGF) in the rat CNS: Absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Synaptic mechanisms for long-term depression.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Sleep states and learning: a review of the animal literature

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Benzodiazepine-GABA receptor-ionophore complex. Current concepts

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Neuronal loss and GABAergic innervation in the basal forebrain

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Chronic exposure to flumazenil: anxiolytic effect and increased exploratory behavior.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Neurons that say NO

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Intraseptal injection of GABA and benzodiazepine receptor ligands alters high-affinity choline transport in the hippocampus.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

The benzodiazepine antagonist, Ro 15-1788, increases REM and slow wave sleep in the dog.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Increased responsivity of dentate granule cells during nictitating membrane response conditioning in rabbit.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1995.6.3.221

21 January 2018

Identifiers

10.1515/REVNEURO.1995.6.3.221

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41039991&oldid=2093389590"